Document is current
Any future updates will be listed below
-
Authors
Nakamura, Tomoya
Dinh, Trong Ha
Asai, Makoto
Nishimaru, Hiroshi
Matsumoto, Jumpei
Setogawa, Tsuyoshi
Ichijo, Hiroyuki
Honda, Sokichi
Yamada, Hiroshi
Mihara, Takuma
Nishijo, Hisao
-
Funding
Funding for this research was provided by:
Astellas Pharma
Takeda Science Foundation
University of Toyama
- License Information
-
More Information
Article History
Received: 26 May 2022
Accepted: 13 September 2022
First Online: 30 September 2022
Declarations
:
: The subjects were treated in strict compliance with the Guidelines for the Care and Use of Nonhuman Primates in Neuroscience Research of the Japan Neuroscience Society and the Institutional Animal Care and Use Committee of Astellas Pharma Inc. This study was approved by the Institutional Animal Care and Use Committee of Astellas Pharma Inc. and accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (Permit Number: C-T12053, C-T12128, C-T13229, C-T14140, C-T15210, C-T15533, C-T17016, and C-T18027). All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments.
: Not applicable.
: MA, SH, and TM are employed by Astellas Pharma Inc. from which this study received funding. HY was employed by Astellas Pharma Inc. during conducting the study. Other authors declare no competing interests.
